Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay
Yuri E. Nikiforov(University of Pittsburgh Medical Center), Marina N. Nikiforova(University of Pittsburgh Medical Center), William E. Gooding(UPMC Hillman Cancer Center), Steven P. Hodak(New York University), Christopher J. Coyne(University of Pittsburgh), Mitchell Tublin(University of Pittsburgh), Shane O. LeBeau(University of Pittsburgh), Umamaheswar Duvvuri(City University of New York), Raja R. Seethala(University of Pittsburgh), Linwah Yip(University of Pittsburgh), Simion I. Chiosea(University of Pittsburgh), Sally E. Carty(University of Pittsburgh), Robert L. Ferris(University of Pittsburgh), N. Paul Ohori(University of Pittsburgh)
Cited by 502
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples
|The Journal of Clinical Endocrinology & Metabolism|2011|787